(Q46745352)

24 December 2017

title

Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice (English)

1 reference

24 December 2017

(9R,10R)-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene

0 references

1 reference

1 reference

Si-Yuan Pan

1

1 reference

24 December 2017

Hang Dong

2

1 reference

24 December 2017

Xing-Ye Zhao

3

1 reference

24 December 2017

Chun-Jing Xiang

4

1 reference

24 December 2017

Hai-Yan Fang

5

1 reference

24 December 2017

Wang-Fun Fong

6

1 reference

24 December 2017

Zhi-Ling Yu

7

1 reference

24 December 2017

Kam-Ming Ko

8

1 reference

24 December 2017

Journal of Pharmacy and Pharmacology

publication date

March 2008

1 reference

16 September 2022

1 reference

24 December 2017

volume

60

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

399-403

1 reference

24 December 2017

https://api.unpaywall.org/v2/10.1211/jpp.60.3.0017?email=unpaywall_01@example.com

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Review article: Drug therapy for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Fatty liver and the metabolic syndrome among Shanghai adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Hepatic steatosis in obese patients: clinical aspects and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Nonalcoholic fatty liver disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARalpha activations in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Treatment strategies in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.3.0017

High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia1

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

A novel experimental model of acute hypertriglyceridemia induced by schisandrin B

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

Inductive effects of fenofibrate and metabolism of phenobarbital

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

Fenofibrate: metabolic and pleiotropic effects

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.3.0017

Identifiers

DOI

10.1211/JPP.60.3.0017

1 reference

24 December 2017

1 reference

24 December 2017